Discovery of peptidic anti-­myotoxins

Johanna Bjärtun, Andreas Hougaard Laustsen, Andreas Munk, Bruno Lomonte, Brian Lohse

    Research output: Contribution to conferencePosterResearchpeer-review

    73 Downloads (Pure)


    More than 2.5 millions envenomations and 125.000 death occur each year due to snakebite. Current antivenoms consist of immunoglobulinesderived from animals, and they are therefore associated with a high risk of adverse reactions in humans. The use of synthetic peptidic antitoxinsmay lead to safer and more effective antivenoms. This research reports the discovery of peptidic antitoxins against myotoxin II from B. asper.
    Original languageEnglish
    Publication date2016
    Number of pages1
    Publication statusPublished - 2016
    EventExamenssymposium, Uppsala Universitet 2016 - Uppsala, Sweden
    Duration: 15 Jan 201615 Jan 2016


    ConferenceExamenssymposium, Uppsala Universitet 2016


    Dive into the research topics of 'Discovery of peptidic anti-­myotoxins'. Together they form a unique fingerprint.

    Cite this